HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Manjusha Gaglani Selected Research

COVID-19 Vaccines

10/2022Effectiveness of the Ad26.COV2.S (Johnson & Johnson) Coronavirus Disease 2019 (COVID-19) Vaccine for Preventing COVID-19 Hospitalizations and Progression to High Disease Severity in the United States.
8/2022Neutralizing Antibody Response to Pseudotype Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Differs Between mRNA-1273 and BNT162b2 Coronavirus Disease 2019 (COVID-19) Vaccines and by History of SARS-CoV-2 Infection.
7/2022Pediatric Research Observing Trends and Exposures in COVID-19 Timelines (PROTECT): Protocol for a Multisite Longitudinal Cohort Study.
6/2022Vaccine Effectiveness of Primary Series and Booster Doses against Omicron Variant COVID-19-Associated Hospitalization in the United States.
3/2022Effectiveness of 2-Dose BNT162b2 (Pfizer BioNTech) mRNA Vaccine in Preventing SARS-CoV-2 Infection Among Children Aged 5-11 Years and Adolescents Aged 12-15 Years - PROTECT Cohort, July 2021-February 2022.
2/2022Clinical Severity and mRNA Vaccine Effectiveness for Omicron, Delta, and Alpha SARS-CoV-2 Variants in the United States: A Prospective Observational Study.
1/2022COVID-19 vaccine perceptions and uptake in a national prospective cohort of essential workers.
1/2022Vaccine effectiveness against COVID-19 among symptomatic persons aged ≥12 years with reported contact with COVID-19 cases, February-September 2021.
1/2022Incidence of SARS-CoV-2 infection among COVID-19 vaccinated and unvaccinated healthcare personnel, first responders, and other essential and frontline workers: Eight US locations, January-September 2021.
12/2021Interim Estimate of Vaccine Effectiveness of BNT162b2 (Pfizer-BioNTech) Vaccine in Preventing SARS-CoV-2 Infection Among Adolescents Aged 12-17 Years - Arizona, July-December 2021.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Manjusha Gaglani Research Topics

Disease

59Human Influenza (Influenza)
10/2022 - 02/2014
35COVID-19
11/2022 - 01/2021
24Infections
10/2022 - 02/2014
3Breakthrough Infections
01/2022 - 01/2021
2Disease Progression
10/2022 - 11/2021
2Pneumonia (Pneumonitis)
01/2022 - 01/2018
2Respiratory Tract Infections (Respiratory Tract Infection)
01/2020 - 01/2018
2Cough
01/2020 - 05/2016
1Coinfection
10/2022
1Thrombosis (Thrombus)
04/2022
1Thrombocytopenia (Thrombopenia)
04/2022
1Respiratory Insufficiency (Respiratory Failure)
03/2022
1Asymptomatic Infections
08/2021
1Drug-Related Side Effects and Adverse Reactions
12/2020
1Frailty
01/2019
1Fever (Fevers)
01/2018
1Sinusitis
01/2018
1Pharyngitis (Sore Throat)
01/2018
1Bronchitis
01/2018
1Herpesviridae Infections (Herpesvirus Infection)
02/2014
1Mumps
10/2011
1Rubella (German Measles)
10/2011
1Measles
10/2011
1Chickenpox
10/2011

Drug/Important Bio-Agent (IBA)

74VaccinesIBA
11/2022 - 10/2011
38Influenza Vaccines (Influenza Vaccine)FDA Link
03/2022 - 02/2014
23mRNA VaccinesIBA
10/2022 - 01/2021
18COVID-19 VaccinesIBA
10/2022 - 04/2021
16Messenger RNA (mRNA)IBA
11/2022 - 01/2021
10BNT162 VaccineIBA
08/2022 - 01/2021
7RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA
01/2022 - 02/2014
6Antiviral Agents (Antivirals)IBA
03/2022 - 02/2014
52019-nCoV Vaccine mRNA-1273IBA
08/2022 - 01/2021
5Hemagglutinins (Hemagglutinin)IBA
01/2021 - 01/2015
3AntibodiesIBA
10/2022 - 01/2015
3Neutralizing AntibodiesIBA
08/2022 - 01/2022
3Anti-Bacterial Agents (Antibiotics)IBA
12/2020 - 09/2014
2Ad26COVS1IBA
10/2022 - 10/2021
2Inactivated VaccinesIBA
01/2021 - 12/2018
2Attenuated VaccinesIBA
01/2021 - 10/2017
2Neuraminidase (Sialidase)IBA
09/2016 - 01/2015
1Proteins (Proteins, Gene)FDA Link
10/2022
1NucleoproteinsIBA
10/2022
1COVID-19 vaccine booster shotIBA
04/2022
1Dihydrotachysterol (AT 10)IBA
12/2021
1Nucleic AcidsIBA
11/2021
1Immunoglobulin G (IgG)IBA
09/2021
1Combined VaccinesIBA
01/2021
1Viral RNAIBA
01/2021
1CI 22IBA
01/2019
1Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
01/2019
1Hepatitis A Vaccines (Hepatitis A Vaccine)IBA
10/2011

Therapy/Procedure

9Ambulatory Care (Outpatient Care)
04/2022 - 09/2014
2Artificial Respiration (Mechanical Ventilation)
10/2022 - 11/2021
1Critical Care (Surgical Intensive Care)
01/2022
1Mechanical Ventilators (Ventilator)
12/2021
1Length of Stay
12/2021
1Therapeutics
09/2014